Bleeding Endpoints (Included Surgical Site)
Enoxaparin, N = 1508
Apixaban, N = 1501
% of Patients Experiencing
Bleeding Event
10
8
6
4
2
0
0.93%
n = 14
0.60%
n = 9*
4.77%
n = 72
3.53%
n = 53
8.36%
n = 126
6.93%
n = 104
Major Bleeding
Major + CRNM Bleeding
All Bleeding
ELIQUIS increases the risk of bleeding and can cause serious, potentially fatal, bleeding